Protagonist Therapeutics (PTGX) Non-cash Items (2016 - 2025)

Protagonist Therapeutics has disclosed Non-cash Items across 10 years of filings, most recently posting $501.3 million for Q4 2025.

• Non-cash Items for Q4 2025 came in at $501.3 million, up 227.86% year-over-year; the trailing twelve-month figure through Dec 2025 was $501.3 million (up 227.86% YoY), and the FY2025 annual result was $501.3 million, up 227.86% from the prior year.
• Non-cash Items came in at $501.3 million for Q4 2025 at Protagonist Therapeutics, up from $152.9 million in the prior quarter.
• In the past five years, Non-cash Items ranged from a high of $501.3 million in Q4 2025 to a low of $1.7 million in Q2 2022.
• The 5-year median for Non-cash Items is $60.0 million (2023), against an average of $95.3 million.
• Across the five-year window, Non-cash Items plunged 99.02% in 2022 and surged 5323.53% in 2023, its largest moves.
• Protagonist Therapeutics' Non-cash Items stood at $102.7 million in 2021, then tumbled by 93.28% to $6.9 million in 2022, then surged by 769.57% to $60.0 million in 2023, then jumped by 154.83% to $152.9 million in 2024, then soared by 227.86% to $501.3 million in 2025.
• The last three Non-cash Items figures came in at $501.3 million (Q4 2025), $152.9 million (Q4 2024), and $60.0 million (Q4 2023), per Business Quant data.